Inspiring Dry Powder Inhalation

Inspiring Dry Powder Inhalation

Friday • May 5, 2023 • 8:30–10:00 AM CET • Auditorium Level 3
Moderator: Michael Hindle, Ph.D.

Addressing Challenges of High Dose Powder Delivery: Formulation and Device Considerations
Eunice Costa
Hovione
Shaping the Future of Inhaled Powders: Spray Drying siRNA Lipid Nanoparticles for Dry Powder Pulmonary Delivery
Olivia Merkel
Ludwig-Maximilians-University Munich
Inhalation Blend Microstructure: Identifying Metrics to Address Q3 Equivalence using Semi-automated X-Ray Microscopy
Parmesh Gajjar, University of Manchester and Darragh Murnane, University of Hertfordshire
University of Manchester

Discover More

Integrated Development for Capsule-Based DPIs - Solving New Challenges
Susana Saldanha, João Pereira and Mirjam Kobler
Hovione and H&T Presspart
Spray-Drying Process Considerations for Inhaled Biotherapeutic Dry Powders
Kimberly Shepard
Lonza
JK
Use of Isothermal Dry Particle Coating (iDPC) for the Development of High Dose Dry Powder Inhalers
David Wyatt and Jasdip Koner
Aston Particle Technologies
MB
Impact of Active Pharmaceutical Ingredient Span and the Amount of Lactose Fines on Dry Powder Inhaler Formulation Performance
Maria Isabel Bogalo Huescar
DFE Pharma
MM
Understanding the Impact of In-Line Sieving on the Filling Behavior of Different Inhalation Powders Using Drum Filling Technology
Karin Marek and Mohit Mehta
Harro Höfliger
On the Use of Process Analytical Technology to Expedite Spray Dried DPI Formulations
Maria Ines Lopes
Hovione
Room Temperature 24-Month Stability of Spray-Dried Bevacizumab Formulation for Dry Powder Inhaler
Kimberly Shepard
Lonza
The Effect of Mixing on the Dispersibility of Adhesive Mixtures for Inhalation
Kyrre Thalberg
Lund University
Production of Amorphous Solid Dispersions at Low Temperature by Electrostatic Spray Drying: Delivery of Thermolabile Compounds with Enhanced Bioavailability
Rodrigo Amorim
Micro-Sphere SA
Budesonide Nanocrystal Manufacturing Using Controlled Expansion of Supercritical Solutions (CESS®)
Barry Derham
Nanoform
AZ
Assessment of the Realistic Performance of Orbital™ Device Loaded with Model Fluticasone Proprionate Blends Manufactured by Low Shear and Isothermal Dry Particle Coating
Irene Rossi and Antonia Zapata
Nanopharm
Effect of Capsule-Based Dry Powder Inhaler User Training on In Vitro Performance
Yannick Baschung
Solvias
Development and Characterization of a Spray-Dried Inhalable Ciprofloxacin-Quercetin Co-Amorphous System Against Pseudomonas Aeruginosa Biofilms
Nasser Ahmed Mohammed Al-hajj
South East Technological University
Gelatin Microcapsules as a Platform to Increase Ciprofloxacin Efficacy Against Bacterial Biofilms
Tania Bahamondez-Canas
Universidad de Valparaíso
Enhancing Extended-Release Profiles of Gelatin Microcapsules Using Ionotropic Gelation and Lipid Coating by Spray Drying
Daniel Moraga-Espinoza
Universidad de Valparaíso
L-Leucine as a Dispersibility Enhancer in Fully Crystalline Spray-Dried Systems
Mani Ordoubadi
University of Alberta
Rethinking Dose Delivery and Product Efficiency for the Sustainable Development of Generic DPIs
Francesca Buttini
University of Parma
Evaluation of the Impact of Polymorphic Forms of Lactose Having the Same Particle Size on Dry Powder Inhaler Aerodynamic Performance
Çigdem Acar Topaloglu
World Medicine
CO-ORGANIZERS
CONFERENCE SUPPORTERS
WORKSHOP PRESENTERS
EXHIBITORS

Exhibitors

↑ Back to Top